ArticleDiscover oncology2026

Novel therapeutic potential of the PARP inhibitor talazoparib in synovial sarcoma and its combined effect with ATR inhibitor.

Noritaka Honda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.